E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma

NCT01133977 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IV Melanoma

Interventions

DRUG: Lenvatinib
DRUG: Lenvatinib
DRUG: Dacarbazine

Sponsor

Eisai Inc.

Collaborators

[object Object]